CIK: 1106813 - Address: C/o Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111-3-8-41286914
S%wins10010010000050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/14/13 17:53
3/11/13
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRuscher Robert PNCDM.adm40011.400350D
3/14/13 17:53
3/11/13
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRuscher Robert PNCDS.adm-1,44741.250-35-1000D
3/13/13 18:13
3/11/13
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRuscher Robert PNCDM.d40011.400357D
3/13/13 18:13
3/11/13
FURXFuriex Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRuscher Robert PNCDS.dm-1,15741.580-28-797D
9/9/03 09:29
9/5/03
SLXPSalix Pharmaceuticals LtdHealthDrugPharmaceutical PreparationsRuscher Robert LNCDOExec CB S-2,24117.936-125-20504D33128255687156465-3-8-412869

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact